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hticense.Abstract The aim of the study: To evaluate the diagnostic accuracy of magnetic resonance chol-
angiopancreatography in patients with cholestatic jaundice.
Patients and methods: Clinical, laboratory and investigational data were evaluated from 50 patients
with cholestastic jaundice. MRCP ﬁndings were compared with ERCP or operative ﬁndings and
appropriate clinical endpoints.
Results: The ERCP or operative ﬁndings and appropriate clinical endpoints revealed 23 patients
with intra or extra hepatic biliary dilatation and 27 patients without intra or extra hepatic biliary
dilatation. As regards the 23 patients with biliary dilatation, biliary dilatation was evident in 19
patients by U/S versus 23 patients by MRCP. ERCP was successful in 20 patients (87%) and
was not done in three patients (13%). In cases of obstructive jaundice the sensitivity of MRCP
was 100% versus 86% in choledocholithiasis and malignant detection, respectively p value <0.05.
Conclusion: MRCP is highly sensitive and speciﬁc for biliary dilatation and avoids the need for
invasive imaging in most patients with cholestasis. MRCP permits reservation of ERCP to patients
with a high probability of therapeutic intervention.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.558198; fax: +20 222687239.
(A. Amin Abu El Maati).
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Cholestasis is any condition in which the ﬂow of bile from the
liver is slowed or blocked. Cholestasis broadly fall into two cat-
egories: those where there is a mechanical blockage in the duct
system – obstructive or extrahepatic cholestasis. And those
where there are disturbances in bile formation – hepatocellular
or intrahepatic cholestasis (1).
Extrahepatic causes are further sub-divided into intra-
ductal and extra-ductal. Neoplasm, choledocholithiasis, biliarygyptian Society of Radiology and Nuclear Medicine.
3.03.004
Table 1 Summary of MRCP imaging parameter.
Parameter Thin slab Thick slab
Echo time (ms) 800 900
Repetition time (ms) NA NA
Bandwidth 31.25 31.25
Acquisition plane Coronal Rotating oblique
coronal
Field of view (cm) 42 · 37.8 26 · 26
Section thickness (mm) 3 mm (no intersection gap) 40 mm
138 E.Y. ElSayed et al.stricture, parasites and primary sclerosing cholangitis lead to
intra-ductal obstruction. External compression of biliary chan-
nels by neoplasm, pancreatitis or cystic duct stones with subse-
quent gallbladder distention lead to extra-ductal obstruction.
Obstructive jaundice is a clinical terminology used for a condi-
tion associated with signiﬁcant morbidity and mortality. Early
and accurate diagnosis is very important in obstructive
jaundice so that its outcomes should be controlled as early
as possible (2).
Although abdominal ultrasonography (U/S) is non-invasive,
quick and inexpensive, yet it is very operator and patient
dependent (3).
Endoscopic retrograde cholangiopancreatography (ERCP)
is currently the ‘gold standard’ for the diagnosis of biliary
obstruction. It is one of the several invasive direct cholangiog-
raphy techniques. However, it is an imperfect diagnostic tool
and other procedures may be more appropriate gold standards
for diagnosis in the future (4).
Magnetic resonance cholangiopancreatography (MRCP) is
an alternative to diagnostic ERCP for imaging the biliary tree
and investigating biliary obstruction. MRCP was developed in
1991 and techniques are continuing to improve (5). Although
ERCP is still the standard of reference for imaging the pancre-
aticobiliary system, there are speciﬁc advantages of MRCP
over ERCP. MRCP (a) is noninvasive; (b) is cheaper; (c) uses
no radiation; (d) requires no anesthesia; (e) is less operator
dependent; (f) allows better visualization of ducts proximal
to an obstruction; and (g) when combined with conventional
T1- and T2-weighted sequences, allows detection of extraduc-
tal disease. The only disadvantage of MRCP is that interven-
tion is not possible, yet it is possible and can be therapeutic
with ERCP (6).
The aim of this study is evaluating the diagnostic accuracy
of magnetic resonance cholangiopancreatography in patients
with cholestatic jaundice.
2. Patients and methods
2.1. Patients
Fifty patients with cholestatic jaundice were enrolled in our
study, they were identiﬁed from the Ain Shams University Spe-
cialized Hospital during the period from August 2011 to June
2012. All patients were subjected to the following: medical his-
tory and clinical examination, laboratory investigations (liver
proﬁle, pancreatic enzymes, viral markers, autoimmune mark-
ers, tumor markers), abdominal ultrasound was the initial
screening investigation done for all patients, followed by
MRCP. In biliary dilation ERCP was the reference imaging
technique. When ERCP failed, PTC and operative CBD explo-
ration were the reference while the clinical endpoints in cases
without biliary dilatation were the reference standards.
2.2. Ultrasound
Gray-scale US of the entire abdomen was performed in all pa-
tients by an expert radiologist using a 3.75-MHz convex-array
transducer (GE, LOGIC 900, PRO series). Routine gallblad-
der examination should be conducted on an adequately dis-
tended gallbladder whenever possible. In most cases, fasting
prior to elective examination will permit adequate distensionof a normally functioning gallbladder. The gallbladder evalua-
tion included long-axis and transverse views obtained in the
supine position. Other positions such as left lateral decubitus,
erect, or prone may be helpful to evaluate the gallbladder and
its surrounding areas completely. Measurements were taken to
determine gallbladder wall thickening. If the patient presented
with pain, tenderness to transducer compression was assessed.
The intrahepatic ducts were evaluated by obtaining views of
the liver demonstrating the right and left branches of the portal
vein.
Doppler was used to differentiate hepatic arteries and por-
tal veins from bile ducts. The intrahepatic and extrahepatic bile
ducts were evaluated for dilatation, wall thickening, and intra-
luminal ﬁndings like stones or masses. The bile duct in the por-
ta hepatis was measured and documented for any pathology.
When visualized, the distal common bile duct in the pancreatic
head should be evaluated. The pancreatic head was evaluated
for any pathology. Also the entire pancreas should be scanned
for dilated ducts +/ stones, calciﬁcations, and focal or dif-
fuse pathology.
2.3. ERCP
Patients routinely undergo intravenous sedation. Patients lie in
the left lateral decubitus position for introduction of the endo-
scope into the duodenum and are then turned into the prone
oblique position. If cannulation of the biliary tree is difﬁcult,
a ﬂexible guide wire or sphincterotome is used. The inferior
submucosal papillary sphincter is cut by sphincterotomy.
2.4. MRCP
Patients are fasted for 4 h prior to the study in order to reduce
ﬂuid secretions within the stomach and duodenum, reduce
bowel peristalsis and promote gallbladder distension. MRCP
was performed on a 1.5T superconducting magnet system
(General Electric Corp, Milwaukee, WI, USA), using a phased
array body coil. Each patient underwent imaging with 2D
SSFSE (single shot fast spin echo) MRCP sequences, which
included coronal thin section (thin slab) imaging and rotating
oblique coronal thick-slab MR imaging.
Imaging parameters are summarized in Table 1. Breath holds
for thin-section 2D SSFSE imaging were at end inspiration after
two preceding full respiratory cycles. Thick-slabMR imageswere
obtained at end inspiration of sequential breath holds, after expi-
ration and repeat full inspiration. The 2D SSFSE thin-section
images were obtained with a section thickness of 3 mm and no
gap. The number of coronal images obtained varied from 15 to
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with breath-hold duration of 20–30 s per acquisition.
The 2D SSFSE thick-slab images were obtained as four to
six rotating oblique coronal images with 40-mm-thick sections,
breath-hold duration of 3 s per image.
Technologists prescribed oblique thick-slab images from a
previously performed axial T2-weighted FRFSE sequence with
fat saturation (repetition time ms/echo time ms, 4500/90) and
had sample annotated images to aid in slab placement. The
technologists were instructed at minimum to obtain slabs ori-
ented parallel to the pancreatic head, in a straight coronal
plane, parallel to the pancreatic tail, and centered obliquely
on the middle portion of the common bile duct to cover the bil-
iary tree.
Then MIP reformats were generated. MIP reformats can be
generated in various coronal and sagittal oblique planes. These
sequences as well as MIP reformat are useful in displaying
pancreaticobiliary tree thus can identify congenital anomaliesFig. 1 Type I choledocal cyst: A 22 years old male patient who prese
revealed appreciable fusiform dilatation of the CBD harboring biliary
the repeat scan the gall bladder was seen contracted (arrow in b), ass
coronal MIP as well as thick slab MRCP revealed marked fusiform di
multiple ﬁlling defects within biliary sludge. (f) Preoperative ERCP was choledochal cyst and pancreatic divisum (Figs. 1 and 2).
Also detecting biliary obstruction, deﬁne its level and identify
a potential cause as stones (Fig. 4), benign and malignant stric-
tures (Figs. 3 and 7).
In order to evaluate the duct walls, and any focal parenchy-
mal pathology, 3D fat suppressed T1-weighted GRE sequences
can also be performed. The combination of T1- and T2-
weighted sequences, allows detection of extra ductal disease,
thus adds to the diagnostic value of MRCP, e.g. acute pancre-
atitis (Fig. 5), pancreatic masses (Fig. 6), porta hepatis masses
or lymph nodes (Fig. 8), thus further investigation can be rec-
ommended as appropriate (see Figs. 9 and 10).
2.5. Statistical analysis
Images were independently and blindly reviewed by two expert
radiologists with documentation of the interobserver agree-
ment and variability.nted with right upper quadrant pain. (a–c) Abdominal ultrasound
sludge, which was ﬁrst interpreted as distended gall bladder yet on
ociated intrahepatic biliary radicle dilatation is seen (c). (d and e)
latation of the CBD with dilated intrahepatic biliary radicles, and
as done for the patient.
Fig. 2 Pancreatic divisum: A 45 years old male patient who presented with epigastric pain, and history of recurrent pancreatitis. (a)
Abdominal ultrasound revealed prominent pancreatic shadow with no intra or extra hepatic biliary radicle dilatation. (b) Coronal MIP
reformats show the main pancreatic duct draining into the minor duodenal papilla (arrow), proximal to the insertion of the CBD, which
drains more inferiorly into the major duodenal papilla.
Fig. 3 A 24 years old male patient who presented with jaundice. (a and b) Thin and thick slab MRCP showing stricture in the lower
third of the CBD with smooth margins, symmetric narrowing and gradual tapering with dilated proximal part of the CBD and
intrahepatic biliary radicle dilatation, thus benign CBD stricture was diagnosed. ERCP (not shown) and tissue biopsy conﬁrmed benign
nature of the stricture.
Fig. 4 A 30 years old female patient who presented with jaundice. (a) Axial T2-weighted fat saturated image and (b) Thick slab MRCP
revealed a CBD stone seen as a low signal-ﬁlling defect in the distal CBD (arrow in a) with mild upstream and intrahepatic biliary radicle
dilatation. No gall bladder stones detected.
140 E.Y. ElSayed et al.SPSS statistical software package (Version 17) was used for
data analysis. Data were expressed as mean ± SD for quantita-
tive measures. Using Student’s t test sensitivity, speciﬁcity,
positive and negative predictive values were calculated.
P> 0.05 was considered statistically non signiﬁcant,
P< 0.05 was considered statistically signiﬁcant and P< 0.01
was considered statistically highly signiﬁcant.3. Results
Fifty patients were with cholestatic jaundice of whom 26 (52%)
were females with mean age of 35 years (range
16–64 years). Abdominal pain was the predominant symptom
at presentation (n= 32), followed by jaundice (n= 18).
Fig. 5 A 33 years old female patient who presented with abdominal pain. (a–d) Abdominal ultrasound revealed distended calcular gall
bladder with thickened edematous wall and pericholecystic collection (arrow in a), dilated CBD about 8 mm in diameter, however its distal
end could not be properly assessed. The hepatic ducts were seen dilated (arrows in c). The pancreas was swollen, with mild amount of
peripancreatic ﬂuid (arrow in d). (e) Axial T2-weighted fat sat image revealed diffusely swollen pancreas with peripancreatic ﬂuid
consistent with acute pancreatitis. (d) Coronal thick slab MRCP revealed dilated CBD with attenuated caliber of its distal portion, yet no
deﬁnite CBD stones detected, and no intra hepatic biliary radicle dilatation. It was diagnosed as gall stone pancreatitis that most likely
passed, with swollen pancreas compressing the distal CBD. Follow up study was done (not shown) revealed resolved pancreatitis with
resolved attenuation of distal CBD.
Fig. 6 Pancreatic head carcinoma: a 45 years old male patient who presented with jaundice. (a) Coronal thick slab MRCP showed the
‘double duct’ sign with dilatation of both the CBD and pancreatic duct (arrows) and distension of the gallbladder. Contrast enhanced
MRI was recommended for the patient. (b) Axial T1 post contrast fat saturation image revealed an inhomogenously enhancing irregular
pancreatic head mass (arrow).
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Fig. 8 A 29 years old male patient who presented with obstructive ja
mass at the porta hepatis (arrow) with moderate intrahepatic biliary ra
segment IV (not shown). (b) Coronal MIP revealed moderate diffuse di
abrupt termination at their conﬂuence. Patient was diagnosed as meta
Fig. 9 A 46 years old female patient who had a past history of choled
saturated image revealed signiﬁcantly dilated intrahepatic biliary rad
defects. Complementary CT done for the patient (not shown) reveal
stenosis at the choledochojejunostomy anastomotic site (arrow).
Fig. 7 Coronal MIP reformat shows intrahepatic bile duct
dilatation and a grossly dilated CBD with abrupt distal termina-
tion, dilatation of the main pancreatic duct is seen as well with
ectasia of its side branches. ERCP was done for the patient and
biopsy was obtained from a periampullary tumor.
142 E.Y. ElSayed et al.The results of our study revealed 23 patients with intra or
extra hepatic biliary dilatation, in 27 patients there was no in-
tra or extra hepatic biliary dilatation. The results are summa-
rized in Table 2.
Biliary dilatation was evident in 19 patients by U/S versus
23 by MRCP Table 3.
ERCP was attempted in 23 patients (46%); ERCP was suc-
cessful in 20 patients (87%). In our study, 10 patients under-
went sphincterotomy and stone extraction. In 9 patients stent
was applied, in four of which tissue biopsy was obtained. In
our study there was one case of choledochal cyst for which
ERCP was done as preoperative assessment for any anoma-
lous pancreaticobiliary junction.
ERCP was not done in three patients; two patients had gall
stone pancreatitis with periampullary edema, it failed in one
patient and in the other patient no CBD stones were detected
by MRCP so conservative management was decided and fol-
low up MRCP revealed resolved biliary dilatation which con-undice. (a) Axial T2 weighted fat sat image revealed lymph nodal
dicle dilatation. A hepatic focal lesion was also seen at hepatic sub
latation of intrahepatic biliary radicles and both hepatic ducts with
stases of unknown origin for further metastatic work up.
ochojejunostomy and presented with jaundice. (a) T2 weighted fat
icles being the seat of numerous stones seen as low signal ﬁlling
ed associated pneumobilia. (b) Thick slab MRCP revealed focal
Fig. 10 Missed CBD stone: a 56 years old male patient who presented with jaundice post laparoscopic cholecystectomy (4 weeks earlier).
(a) Axial T2-weighted fat sat image revealed a ﬁlling defect at the proximal part of the common bile duct (arrow). An inhomogenously
hyperintense post operative collection was also seen. (b and c) 3-D and thick slab MRCP revealed the presence of stone at the proximal
CBD seen at a short distance distal to the common hepatic duct with dilated proximal CBD as well as intrahepatic biliary radicles. Distal
CBD is of normal caliber.
Table 2 Different diagnoses in our study.
Patients with biliary dilatation (n= 23) Patients with no biliary dilatation (n= 27)
Diagnosis No. of patients Diagnosis No. of patients
Choledochal cyst 1 (Fig. 1) Pancreatic divisum 2 (Fig. 2)
Benign CBD stricture 2 (Fig. 3) Hepatic cholestasis 10
Stones 10 (Fig. 4) Gall stone pancreatitis 5
Gall stone pancreatitis n= 3 (Fig. 5)
Malignant obstruction 7 Cholangitis 4
Cancer pancreas n= 3 (Fig. 6) Hepatocellular carcinoma 6
Cholangiocarcinoma n= 2 (Fig. 7)
Hepatocellular carcinoma n= 1
Metastatic porta hepatis lymph node n= 1 (Fig. 8)
Post-operative 3
Biliary ligation n= 1
Anastomotic stricture n= 1 (Fig. 9)
Missed CBD stone n= 1 (Fig. 10)
Table 3 Diagnostic value of MRCP vs. U/S in detection of
biliary dilatation in cholestatic jaundice.
U/S (%) MRCP (%) P value
Sensitivity 65.5 95.7 <0.05
Speciﬁcity 85.2 96.3 <0.05
PPV 87.9 95.7 <0.05
NPV 74.2 96.3 <0.05
Eﬃcacy 78 96 <0.05
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operative choledocojejunostomy.
When ERCP failed, comparative imaging data were avail-
able from other invasive procedures, intra operative cholangi-
ography, or percutaneous cholangiography.
The combination of T1 and T2 sequences guided the diag-
nosis of 19 cases namely cases of gall stone pancreatitis, pan-
creatic carcinoma, metastatic porta hepatis lymph nodes,
144 E.Y. ElSayed et al.hepatocellular carcinoma, and further dedicated investigations
were done when indicated.
In cases of obstructive jaundice detected in our study (23
patients) ultrasound could not depict the level and/or the cause
of obstruction in 6 patients. The sensitivity of U/S was about
77% in both malignant and choledocholithiasis detection while
the sensitivity of MRCP 100% in choledocholithiasis versus
86% in malignant detection P< 0.05).4. Discussion
When evaluating a case of cholestatic jaundice the aim of the
radiologist is to conﬁrm the presence of obstruction and to
identify its location, extent and possible cause. Ultrasound
has traditionally been used as the initial screening procedure
because of its many advantages, which include its availability,
its cost effectiveness, and no requirement of contrast material
and lack of ionizing radiation. However, although it is well sui-
ted to visualize the common hepatic duct and proximal CBD,
one of its major limitations is assessment of the distal CBD
and pancreas, which are often obscured by bowel gas in about
30–50% of patients. Obesity is also an important limiting fac-
tor. Other cases missed by ultrasound were stricture and cases
of small mass lesions involving the head of pancreas (7).
In our study ultrasound could not depict the level and/or
the cause of obstruction in six patients. The sensitivity of U/
S was about 77% in both malignant and choledocholithiasis
detection while the sensitivity of MRCP 100% in choledocho-
lithiasis versus 86% in malignant detection (P< 0.05). These
results were similar to those obtained by Upadhaya et al.,
2006 who found that ultrasound could identify the cause of
obstruction in 77% of cases.
ERCP, since ﬁrst appearance in 1970, in the evaluation of
biliary tree, also owing to its therapeutic feature, continues
to be the gold standard imaging method. But, today, in addi-
tion to high diagnostic accuracy of MRCP, as an invasive
method the morbidity and mortality rate of ERCP reaches
about 7% and 1%, and this limits the use of ERCP for diag-
nosis. Also, in the case of hepaticojejunostomy and choledo-
chojejunostomy, ERCP cannot be performed; in the case of
gastric resection, retroperitoneal neoplasm, duodenal divertic-
ulum, and ampullary edema, performing ERCP is hard.
ERCP, dependent on the practitioner, in some of the cases
failed (3–18%) or was inadequate (8). As in our study ERCP
was not done in three patients (13%); one due to history of
choledochojejunostomy, the other two cases had gall stone
pancreatitis, in one of them it failed due to periampullary ede-
ma and in the other conservative management and follow up
were decided as no CBD stones detected on MRCP.
In our study 27 patients had no intra or extra hepatic bili-
ary dilatation (5 gall stones pancreatitis, 4 cholangitis, 2 pan-
creatic divisum, 10 hepatic cholestasis and 6 hepatocellular
carcinoma.
The use of MRCP for the initial ‘‘screening’’ of patients at
risk of choledocholithiasis permits selection for more invasive
procedures based on a high probability of therapeutic interven-
tion. It offers a safer and more acceptable alternative to diag-
nostic ERCP (9). MRCP carries an additional advantage of
diagnosing abnormalities of the biliary tree including duplica-
tion, choledochal cyst, pancreatic divisum and cholangiocarci-
noma. The superior sensitivity of MRCP over ERCP indiagnosing primary sclerosing cholangitis (10,11), and intrahe-
patic calculi has been well documented (12). A disadvantage of
MRCP is that currently no therapeutic options are available
for the management of common duct calculi.
In our studyMRCPhad a negative predictive value (NPV) of
96.3% to exclude biliary dilatation with a sensitivity of 95.7%
and a positive predictive value (PPV) to conﬁrm biliary dilata-
tion of 95.7% with a speciﬁcity of 96.3%. The diagnostic accu-
racy of MRCP in the diagnosis of biliary dilatation was 96%.
Sugiyama et al. reported a sensitivity of 100% from their
series of 101 patients (13), but Mendler et al. found MRCP less
sensitive for smaller stones (less than 3 mm) (14).
Our study reported that patients undergoing MRCP for
suspected biliary dilatation had a sensitivity for the diagnosis
100% vs. 86% in choledocholithiasis and malignant detection,
respectively.
The median sensitivity for choledocholithiasis (13 studies)
was 93% and the median speciﬁcity 94%. Reported sensitivi-
ties for malignancy were somewhat lower, ranging from 81%
to 86%, and speciﬁcities ranged from 92% to 100%. There
was some evidence that MRCP is an accurate diagnostic test
in comparison to ERCP. The probability of avoiding unneces-
sary diagnostic ERCP is estimated at 30%. These patients
could avoid the unnecessary risk of complications and death
associated with diagnostic ERCP, and substantial cost saving
would be gained. There is some evidence that MRCP is an
accurate investigation compared with diagnostic ERCP,
although the values for malignancy compared with choledo-
cholithiasis were somewhat lower (15).
Shanmugam et al. (16) found that in 51 patients, ERCP
was performed unsuccessfully, whereas MRCP in the same
group of patients did not show evidence of ductal calculi. This
cohort of patients were managed conservatively and recovered
without sequelae. This implies that invasive ERCP could have
been potentially avoided in some patients. Avoiding these
examinations would have effectively resulted in considerable
resource release.
In our study there was one false positive MRCP (stone and
intra hepatic biliary dilatation) (Fig. 11). The exact cause of
that false positive result was unknown, but we suspected that
it was possibly a passed stone (at the time interval between pre-
forming MRCP and ERCP), an artifact, or could be attributed
to the explanation given by Grifﬁn et al. (17) as they stated
that pulsatile vascular compression from adjacent vessels
might mimic a stricture. The commonest site of extrinsic vascu-
lar compression is the common hepatic duct, followed by the
left hepatic duct, both due to the right hepatic artery crossing
its posterior aspect. The mid portion of the CBD may also be
narrowed due to the gastro-duodenal artery. Pseudo-obstruc-
tion is typically seen as a band like compression with minimal
proximal dilatation, and it should not be misdiagnosed as a
bile duct tumor or biliary stone.
The performance of MRCP in enabling differentiation of
benign strictures (smooth margins, symmetric narrowing and
gradual tapering) from strictures caused by extrahepatic chol-
angiocarcinoma (irregular margins, asymmetric or Abrupt
narrowing) is comparable with that of ERCP (18).
ERCP may have some limitations as regards identiﬁcation
of distal bile duct stenosis in cases of critical stenosis. The
non-invasive nature and panoramic capabilities of MRCP
and the fact that no contrast material is needed make MRCP
the examination of reference in the diagnosis of malignant
Fig. 11 A 50 years old female patient who presented with right hypochondrial pain. (a) Coronal MIP revealed multiple gall bladder
calcular ﬁlling defects, with relatively higher position of the gall bladder indenting the main hepatic duct. There was a slight dilatation of
the caliber of the CBD with a small ﬁlling defect seen at its proximal portion that was interpreted as CBD stone. (b) Axial T2 fat sat image
revealed minimal pericholecystic edema denoting an acute attack on top of chronic cholecystitis. ERCP was done for the patient (not
shown) revealed normal CBD without any calculi denoting false positive result obtained by MRCP, and the ﬁlling defect seen could be an
artifact, vascular compression or passed stone.
Fig. 12 A 40 years old male patient who presented with jaundice. a and b Thick slab MRCP: (a) a few small gall bladder calculi are seen
(arrow). (b) Mild dilatation of the CBD as well as intrahepatic biliary radicles with no evidence of calculi or strictures so it was thought to
be a passed stone, however, this was a false negative case as it was proved latter by ERCP and tissue biopsy to be malignant stricture at the
distal CBD.
Diagnostic value of magnetic resonance cholangiopancreatography in cholestatic jaundice 145stenosis of the distal bile duct, also thanks to its ability to visu-
alize the entire biliary tree in the presence of critical strictures
of the common bile duct. The rationale for the use of ERCP
lies in the possibility of taking histological samples and per-
forming minimally invasive surgical interventions (19). In
our study there was one case of false negative MRCP (missed
malignant stricture) (Fig. 12), probably because the stricture
was at the distal most part of the CBD, the cause of biliary
dilatation at MRCP was attributed to a passed stone as the pa-
tient had calcular gall bladder, yet ERCP and tissue biopsy re-
vealed distal CBD cholangiocarcinoma.
Evaluation of the biliary-enteric anastomosis is difﬁcult by
ERCP due to altered bowel anatomy. Long-term complica-
tions of biliary enteric anastomosis include recurrent obstruc-
tion secondary to anastomotic stenosis/stricture, cholangitis,intrahepatic stones and dilated bile ducts. MRCP can show
the site of anastomosis, status of the intrahepatic ducts, stones
and strictures (20).
In our study one case of stricture at the site of choledocojej-
unostomy was successfully diagnosed by MRCP as proven by
surgical data (in which ERCP had failed and could not be
done).
We believe that the small false positive rate for MRCP is
comfortably outweighed by the incidence of the hazards of
‘‘unnecessary’’ ERCP where this is conﬁned to patients in
whom the probability of operative intervention is high.
Clearly, further longitudinal follow-up data must be awaited
for patients with negative MRCP results with transient jaun-
dice or pancreatitis in whom a decision is made not to under-
take ERCP.
146 E.Y. ElSayed et al.Magnetic resonance cholangiopancreatography (MRCP) is
an alternative to diagnostic endoscopic retrograde cholangio-
pancreatography (ERCP) for investigating biliary obstruction.
The use of MRCP, a non-invasive procedure, may prevent the
use of unnecessary invasive procedures.
5. Conclusion
MRCP is highly sensitive and speciﬁc for biliary dilatation and
avoids the need for invasive imaging in most patients with sus-
pected obstructive jaundice. MRCP is becoming the initial
imaging tool for the biliary system, with ERCP reserved for
therapeutic indications.
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